Dimethylformamide → {4-[(3-Methoxy-pyrazin-2-ylamino)-methyl]-piperidin-1-yl}-((1R,2R)-2-phenyl-cyclopropyl)-methanone
Reaction equation
[CH3:1][O:2][C:3]1[C:4]([NH:9][CH2:10][CH:11]2[CH2:16][CH2:15][NH:14][CH2:13][CH2:12]2)=[N:5][CH:6]=[CH:7][N:8]=1.ON1[C:22]2[CH:23]=[CH:24][CH:25]=[CH:26][C:21]=2N=N1.Cl.C(N=C=N[CH2:33][CH2:34][CH2:35]N(C)C)C.CN([CH:42]=[O:43])C>C(OCC)(=O)C>[CH3:1][O:2][C:3]1[C:4]([NH:9][CH2:10][CH:11]2[CH2:16][CH2:15][N:14]([C:42]([C@@H:35]3[CH2:34][C@H:33]3[C:21]3[CH:26]=[CH:25][CH:24]=[CH:23][CH:22]=3)=[O:43])[CH2:13][CH2:12]2)=[N:5][CH:6]=[CH:7][N:8]=1Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
A mixture of 4-[(3-methoxy-pyrazin-2-ylamino)-methyl]-piperidine (0.093 g, 0.00042 mol), 1-hydroxybenzotriazole (0.078 g, 0.0005 mol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (0.097 g, 0.0005 mole) and (1R,2R)-2-phenylcyclopropropanecarboxylic acid (T. Riley et al., J. Med. Chem., 15, 1187, 1972) (0.072 g, 0.00044 mol) in DMF (2 mL) were stirred at rt for 18 h. The reaction was diluted with ethyl acetate (30 mL), washed with 10% aqueous sodium bicarbonate (20 mL) followed by brine (10 mL), concentrated in vacuo and chromatographed on silica using 50–100% ethyl acetate/hexane. Crystallization from ether/hexane gave the title compound. M.S.(M+1): 367.
Workup
- washwashed with 10% aqueous sodium bicarbonate (20 mL)
- concentrationconcentrated in vacuo
- customchromatographed on silica using 50–100% ethyl acetate/hexane
- customCrystallization from ether/hexane
Sources & evidence
- ORD record
- ord-25a805e58c79490ebb2e85033407a5bd
- Source dataset
- uspto-grants-2006_05
- Patent number
- US07053089B2
Reaction notes
Loading…